These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Meta-analysis of gene expression profiles identifies differential biomarkers for hepatocellular carcinoma and cholangiocarcinoma. Likhitrattanapisal S; Tipanee J; Janvilisri T Tumour Biol; 2016 Sep; 37(9):12755-12766. PubMed ID: 27448818 [TBL] [Abstract][Full Text] [Related]
3. Bioinformatics Analysis Identifies Protein Tyrosine Kinase 7 (PTK7) as a Potential Prognostic and Therapeutic Biomarker in Stages I to IV Hepatocellular Carcinoma. Zou RC; Liang Y; Li LL; Tang JZ; Yang YP; Geng YC; He J; Luo LY; Li WX; Sun ZW; Yuan HL Med Sci Monit; 2019 Nov; 25():8618-8627. PubMed ID: 31730575 [TBL] [Abstract][Full Text] [Related]
4. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses. Wan Z; Zhang X; Luo Y; Zhao B Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428 [No Abstract] [Full Text] [Related]
5. Multiomics profiling of buffy coat and plasma unveils etiology-specific signatures in hepatocellular carcinoma. Hong J; Eun JW; Baek GO; Cheong JY; Park S; Kim SS; Cho HJ; Lim SB Clin Mol Hepatol; 2024 Jul; 30(3):360-374. PubMed ID: 38486508 [TBL] [Abstract][Full Text] [Related]
6. Comprehensive analysis of transcriptome profiles in hepatocellular carcinoma. Jin Y; Lee WY; Toh ST; Tennakoon C; Toh HC; Chow PK; Chung AY; Chong SS; Ooi LL; Sung WK; Lee CG J Transl Med; 2019 Aug; 17(1):273. PubMed ID: 31429776 [TBL] [Abstract][Full Text] [Related]
7. A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma. Shi M; Chen MS; Sekar K; Tan CK; Ooi LL; Hui KM Eur J Cancer; 2014 Mar; 50(5):928-36. PubMed ID: 24332572 [TBL] [Abstract][Full Text] [Related]
8. Identification of biomarkers for Barcelona Clinic Liver Cancer staging and overall survival of patients with hepatocellular carcinoma. Xu W; Rao Q; An Y; Li M; Zhang Z PLoS One; 2018; 13(8):e0202763. PubMed ID: 30138346 [TBL] [Abstract][Full Text] [Related]
9. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma. Grinchuk OV; Yenamandra SP; Iyer R; Singh M; Lee HK; Lim KH; Chow PK; Kuznetsov VA Mol Oncol; 2018 Jan; 12(1):89-113. PubMed ID: 29117471 [TBL] [Abstract][Full Text] [Related]
10. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data. Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618 [TBL] [Abstract][Full Text] [Related]
11. A systems biology-based classifier for hepatocellular carcinoma diagnosis. Zhang Y; Wang S; Li D; Zhnag J; Gu D; Zhu Y; He F PLoS One; 2011; 6(7):e22426. PubMed ID: 21829460 [TBL] [Abstract][Full Text] [Related]
12. Four differentially methylated gene pairs to predict the prognosis for early stage hepatocellular carcinoma patients. Liu S; Miao C; Liu J; Wang CC; Lu XJ J Cell Physiol; 2018 Sep; 233(9):6583-6590. PubMed ID: 29115664 [TBL] [Abstract][Full Text] [Related]
13. Identification of novel biomarkers for hepatocellular carcinoma using transcriptome analysis. Xia Q; Li Z; Zheng J; Zhang X; Di Y; Ding J; Yu D; Yan L; Shen L; Yan D; Jia N; Chen W; Feng Y; Wang J J Cell Physiol; 2019 Apr; 234(4):4851-4863. PubMed ID: 30272824 [TBL] [Abstract][Full Text] [Related]
14. Novel biomarkers in hepatocellular carcinoma. De Stefano F; Chacon E; Turcios L; Marti F; Gedaly R Dig Liver Dis; 2018 Nov; 50(11):1115-1123. PubMed ID: 30217732 [TBL] [Abstract][Full Text] [Related]
15. Blood gene signature for early hepatocellular carcinoma detection in patients with chronic hepatitis B. Omar H; Lim CR; Chao S; Lee MM; Bong CW; Ooi EJ; Yu CG; Tan SS; Abu Hassan MR; Menon J; Muthukaruppan R; Singh M; Nik Abdullah NA; Ooi BP; Ding RP; Low EJ; Tan F; Novak D; Harris DF; Yang H; Merican I; Liew CC J Clin Gastroenterol; 2015 Feb; 49(2):150-7. PubMed ID: 25569223 [TBL] [Abstract][Full Text] [Related]
16. Bioinformatics Analysis Reveals Distinct Molecular Characteristics of Hepatitis B-Related Hepatocellular Carcinomas from Very Early to Advanced Barcelona Clinic Liver Cancer Stages. Kong FY; Wei X; Zhou K; Hu W; Kou YB; You HJ; Liu XM; Zheng KY; Tang RX PLoS One; 2016; 11(7):e0158286. PubMed ID: 27454179 [TBL] [Abstract][Full Text] [Related]
17. Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients. Zhu GQ; Yang Y; Chen EB; Wang B; Xiao K; Shi SM; Zhou ZJ; Zhou SL; Wang Z; Shi YH; Fan J; Zhou J; Liu TS; Dai Z J Transl Med; 2019 Jun; 17(1):203. PubMed ID: 31215439 [TBL] [Abstract][Full Text] [Related]
18. Construction of a risk score prognosis model based on hepatocellular carcinoma microenvironment. Zhang FP; Huang YP; Luo WX; Deng WY; Liu CQ; Xu LB; Liu C World J Gastroenterol; 2020 Jan; 26(2):134-153. PubMed ID: 31969776 [TBL] [Abstract][Full Text] [Related]
19. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma. Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911 [TBL] [Abstract][Full Text] [Related]
20. Role of microRNA-141-3p in the progression and metastasis of hepatocellular carcinoma cell. Hou X; Yang L; Jiang X; Liu Z; Li X; Xie S; Li G; Liu J Int J Biol Macromol; 2019 May; 128():331-339. PubMed ID: 30695725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]